GFAP and glioblastoma: Despite the huge number of studies on GFAP’s potential as a GBM prognostic and diagnostic marker, more scientists have discussed GFAP’s application in clinics due to the variety of its isoforms and functional and morphological differences among GFAP-positive cell populations [18].